Prevalence and Impact of Obesity on Disease-Specific Outcomes in a Population-Based Cohort of Patients with Ulcerative Colitis.
暂无分享,去创建一个
[1] Jessica L. Barrett,et al. Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. , 2019, The New England journal of medicine.
[2] U. Masood,et al. Effects of obesity on the course of inflammatory bowel disease , 2019, Proceedings.
[3] S. Choukem,et al. Markers of adiposity in HIV/AIDS patients: Agreement between waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index , 2018, PloS one.
[4] E. Loftus,et al. Antibiotic Use and New-Onset Inflammatory Bowel Disease in Olmsted County, Minnesota: A Population-Based Case-Control Study , 2018, Journal of Crohn's & colitis.
[5] Nima Hamidi,et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.
[6] E. Loftus,et al. Incidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010 , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[7] A. Ananthakrishnan,et al. Environmental Hygiene and Risk of Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis , 2016, Inflammatory bowel diseases.
[8] Jana G Hashash,et al. Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.
[9] A. Venn,et al. The association between quitting smoking and weight gain: a systemic review and meta‐analysis of prospective cohort studies , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[10] R. Xavier,et al. Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease , 2015, Inflammatory bowel diseases.
[11] E. Burstein,et al. Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease , 2015, Digestive Diseases and Sciences.
[12] T. To,et al. Inflammatory Bowel Disease in Immigrants to Canada And Their Children: A Population-Based Cohort Study , 2015, The American Journal of Gastroenterology.
[13] A. Ananthakrishnan,et al. Measures of Obesity and Risk of Crohn's Disease and Ulcerative Colitis , 2015, Inflammatory bowel diseases.
[14] L. Leifeld,et al. The effect of body weight on the severity and clinical course of ulcerative colitis , 2015, International Journal of Colorectal Disease.
[15] Y. Shoenfeld,et al. Obesity in autoimmune diseases: not a passive bystander. , 2014, Autoimmunity reviews.
[16] A. Linneberg,et al. Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. , 2014, International journal of epidemiology.
[17] A. Kostic,et al. The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.
[18] L. Wood,et al. A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans. , 2014, Nutrition research.
[19] G. Kaplan,et al. The Increasing Weight of Crohn's Disease Subjects in Clinical Trials: A Hypothesis-generatings Time-trend Analysis , 2013, Inflammatory bowel diseases.
[20] W. Willett,et al. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. , 2013, Gastroenterology.
[21] C. O'Morain,et al. High prevalence of overweight and obesity in adults with Crohn's disease: associations with disease and lifestyle factors. , 2013, Journal of Crohn's & colitis.
[22] M. Long,et al. A clinical review of recent findings in the epidemiology of inflammatory bowel disease , 2013, Clinical epidemiology.
[23] S. Ng,et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. , 2013, Gastroenterology.
[24] E. Riboli,et al. Body Mass Index and the Risk for Crohn's Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The IBD in EPIC Study) , 2013, The American Journal of Gastroenterology.
[25] B. Yawn,et al. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. , 2012, Mayo Clinic proceedings.
[26] C. Bernstein,et al. Association Between the Use of Antibiotics and New Diagnoses of Crohn's Disease and Ulcerative Colitis , 2011, The American Journal of Gastroenterology.
[27] Christopher F. Martin,et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease 12 , 2011, Inflammatory bowel diseases.
[28] L. Peyrin-Biroulet,et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease , 2011, Gut.
[29] B. Yawn,et al. American Journal of Epidemiology Practice of Epidemiology Use of a Medical Records Linkage System to Enumerate a Dynamic Population over Time: the Rochester Epidemiology Project , 2022 .
[30] P. Vandamme,et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives , 2011, Gut.
[31] S. Walsh,et al. A Brief Report of the Epidemiology of Obesity in the Inflammatory Bowel Disease Population of Tayside, Scotland , 2009, Obesity Facts.
[32] M. Wachtel,et al. Adipose Tissue: The New Endocrine Organ? A Review Article , 2009, Digestive Diseases and Sciences.
[33] E. Riboli,et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case–control study within a European prospective cohort study , 2009, Gut.
[34] M. Cravo,et al. A Comprehensive Approach to Evaluate Nutritional Status in Crohn's Patients in the Era of Biologic Therapy: A Case-Control Study , 2007, The American Journal of Gastroenterology.
[35] William J. Tremaine,et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000 , 2007, Inflammatory bowel diseases.
[36] C. Brensinger,et al. The impact of increased body mass index on the clinical course of Crohn's disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[37] É. Lerebours,et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study , 2005, Gut.
[38] F. Carbonnel,et al. Crohn's disease clinical course and severity in obese patients. , 2002, Clinical nutrition.
[39] A. Zinsmeister,et al. Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival , 2000, Gut.
[40] A. Zinsmeister,et al. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. , 1998, Gastroenterology.
[41] R. Sartor,et al. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. , 2017, Gastroenterology.
[42] G. Chrysant,et al. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. , 2013, Journal of the American Society of Hypertension : JASH.
[43] Subrata Ghosh,et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.